Leaflet CAPECITABINA MEDANA 500mg film-coated tablets
Indicated for: cancer
Route of administration: oral
Substance: capecitabine (antimetabolite antineoplastic)
ATC: L01BC06 (Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
A genetic test may be needed before treatment.
Capecitabine is a chemotherapy medication used to treat various types of cancer, including colon, rectal, breast, and stomach cancer. It is a prodrug, meaning it is converted in the body into its active form, 5-fluorouracil (5-FU), which interferes with DNA and RNA synthesis in cancer cells.
Capecitabine is taken orally in tablet form, making it more convenient than other forms of chemotherapy that require intravenous administration. Treatment is usually given in cycles, and the dosage is adjusted based on the patient's weight, overall health, and the type of cancer being treated.
The medication can be used alone or in combination with other chemotherapy drugs or targeted therapies. It is important for patients to strictly follow their doctor's instructions and report any side effects or unusual symptoms.
Common side effects include nausea, vomiting, diarrhea, fatigue, and hand-foot syndrome (redness, swelling, and pain in the palms and soles). In rare cases, more severe complications such as bone marrow suppression or cardiac toxicity may occur. Regular monitoring is essential to ensure the safety and effectiveness of the treatment.
General data about CAPECITABINA MEDANA 500mg
- Substance: capecitabine
- Date of last drug list: 01-07-2013
- Commercial code: W59061006
- Concentration: 500mg
- Pharmaceutical form: film-coated tablets
- Quantity: 120
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for capecitabine
- 150mg
- 300mg
- 500mg